RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2
Project

Rostec will build a Center for High Biomedical Technologies in Surgut

Customers: Government of the Khanty-Mansiysk Autonomous Okrug - Ugra

Khanty-Mansiysk; State and social structures



Project date: 2022/03

2022: Construction plan of the Center for High Biomedical Technologies in Surgut

Holding Schwabe"" of the State Corporation Rostec Foundation for Scientific and Technological Development of the Khanty-Mansiysk Autonomous Okrug - Ugra and concluded an agreement construction on and equipping the Center for High Biomedical Technologies (CVBMT) in. The area of Surgut​ ​ the facility, which will include laboratories for research in the field of regenerative medicine and molecular, geneticists will be 5 thousand square meters. m Rostec announced this on April 14, 2022.

The cost of creating the Unity Park facility is about 4.8 billion rubles, the implementation period is no more than 36 months.

The implementation of the project will create at least 90 jobs for highly qualified specialists. Employees will prepare highly qualified personnel in promising areas of genomic and translational medicine, cellular, microfluidic and bioinformational technologies, personalized and preventive medicine for the provision of medical services in Ugra[1] for[2].

The center's laboratories will create conditions for medical research in the field of replacement of lost organs, experiments on the cultivation of living tissues for transplantation, work on the creation and testing of pharmacological drugs for the treatment of neuro-degenerative diseases in adults and children.

File:Aquote1.png
This is a truly special and very interesting project in terms of its plan - the city of the future, where innovations are born and a whole balanced system of all structural organizations is established. In this great work, we will be engaged in the creation of the Center for High Biomedical Technologies with our laboratory complex, which will combine the goals of health care and science, and most importantly, it will significantly increase the level of quality of life of the local population, "said Sergey Dmitrochenko, Deputy General Director of Schwabe.
File:Aquote2.png

In addition to scientific activities, the Center for High Biomedical Technologies in Surgut will be focused on educational and medical components - here they plan to develop programs of additional professional education in various medical specialties, create network educational programs in cooperation with the Moscow Higher School of Economics, the Leningrad Institute of Precision Mechanics and Optics and Novosibirsk State University.

File:Aquote1.png
Since the signing of this agreement, we can safely declare that the first facility of the scientific and technological center in Surgut "Unity Park" has been officially launched. The Center for High Biomedical Technologies is a complex and very interesting project. For its successful and operational implementation, we now have all the necessary resources: approval of the project by the president, RUSSIAN FEDERATION Vladimir Vladimirovich Putin personal support of the Governor of Ugra, Natalia Vladimirovna Komarova experienced and strong partners in the person of the Shvabe holding, support in the person of the scientific community, whose scientists will expertise the process of building and equipping the TsVBMT with high-tech equipment. The fact that this project is believed and expected is encouraging. I am sure that the TsVBMT will be successfully implemented in reality and will become the base of research achievements in the field of genetics, - said Ilya Kandakov, General Director of the Foundation for Scientific and Technological Development of the Khanty-Mansiysk Autonomous Okrug - Ugra.
File:Aquote2.png

The Scientific and Technological Center, which will be located in Surgut, is an infrastructure project aimed at creating an innovative ecosystem of higher education, science and technological entrepreneurship. The center should bring together more than 200 geneticists, biochemists, bioinformatics, specialists in the field of personalized medicine and engineers.

A subsidiary of Schwabe Moscow will take part in the implementation of the project from the Schwabe holding.

Notes